The ongoing challenging task in the field of nasal drug delivery is the maintenance of an efficient concentration of the active substance in the target area for an adequate period of time. Thus, there is an urgent need to develop effective new strategies for drug delivery to the nose, using cutting edge technology and materials for this particular type of drug delivery. This review gives an account of the critical components of nasal drug delivery and the parameters influencing drug absorption in the nose, including the excipients required for modified drug administration.
Objectives This review aims at gleaning the currently available research reports that relate to 3D printlets for paediatric patients, and especially the excipients used to produce various colours, flavours, shapes and sizes. Methods A thorough literature review on paediatric 3D printed oral solid dosage forms, focusing on the use of colours, flavours and various shapes/dimensions, was conducted with an adjusted time frame between 2017 and 2022. Key findings 3D printlets for paediatric population include the chewable dosage forms (including solid forms and the soft forms or gummies), the swallowing dosage forms, and the orodispersable dosage forms (printlets or films). Researchers have tested many colours, flavours, shapes and dimensions for the chewable formulations production using pectin and gelatin to create gummies or chocolate and cereals. Scientists have also used many methods and excipients to produce printlets with various colours, flavours, shapes and small sizes (minitablets or minicaplets) for the swallowing dosage forms. Concerning the orodispersables, the research was rather limited. Conclusions Compared to conventional oral dosage form manufacturing processes, 3D printing techniques use a different approach. More specifically, these techniques can provide personalisation of dose, shape, size, taste, colour and appropriate drug release rates, which is of paramount importance especially for paediatric patients. With the correct excipients the printlets can serve as ideal dosage forms candidates for the treatment of the paediatric population.
The growth of the global population together with several unpredicted crises such as political, health, and financial, create an environment of uncertainty in which social innovations can be developed to offer stability in people’s lives and create new business development opportunities for the benefit of the economy and the society. One of the undoubted rights of every human being is access to affordable medical treatment. However, the costs and time needed for research and development on new or specialized drugs are not often covered by governmental budgets and initiatives that could make such medicines accessible to all who needed them. Private companies invest tremendous amounts and expect returns on their investments. This gap, between the availability of a drug and its accessibility, created the social need for a generic drug market and the inspiration for advanced innovations to serve it. Research indicates that the price of brand-name drugs can drop up to 80% after the commercialization of a new generic which has the same action and can potentially replace them. The global generic drug market worth is expected to increase from $311.8 billion in 2021 to $442.3 billion in 2026. Excipients represent a market value of $4 billion, accounting for 0.5% of the total pharmaceutical market. The global market of AI was estimated at 43.1 billion in 2020 and is predicted to reach $228.3 billion by 2026 with a 32.7 % CAGR. On the other hand, the revenues of the AI Health market are projected to grow from $6.9 billion in 2021 to $67.4 billion in 2027 reaching $120.2 billion by 2028 with a CAGR of 45.3%.The choice of excipients in drug development is a critical and time-consuming process. Currently, excipients are chosen based on the route of administration, physicochemical characteristics, place of action, and the type of release of the active ingredient. The process involves many quality control tests on the drug such as fragility, dissolution, disintegration, dosage uniformity, and stability, which are repeated when the excipient changes. This laborious and time-consuming process considers a massive number of existing excipients categorized into different functional groups used for different purposes.This paper addresses this challenge and introduces an approach to resolve it using Artificial Intelligence for social innovation in the formulation development industry. Specifically, the paper presents an Expert system (ES) based software architecture to facilitate assess and utilize drug-excipient relationship data scattered in various forms of documentation and/or scientific literature. The inference engine of the ES operates with rule base and case-based reasoning powered by Machine Reading Comprehension (MRC) and Natural Language Processing (NLP) technologies that populate and enrich the knowledge base. The MRC and NLP technologies interpret existing drug formulations and propose potential new drug formulations, based on its physicochemical characteristics.According to research results, the time to introduce a generic drug can be reduced by 30% if there is an indicative formulation to start the process. The eight months gained can be used to market the product. This is a significant amount of time that reduces research and development costs, reduces the time to market, and increases productivity and operations efficiency. The research conducted is based on an extensive literature review, primary research with surveys and interviews but also with the analysis of several case studies to indicate the need for the proposed technology and support the system architecture design. Furthermore, the paper presents the pre and post-condition for adopting such technology, highlights research limitations, and identifies areas of further research to be conducted for the optimization of the technology and its contribution to the global economy and society.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.